Literature DB >> 29983222

Direct bilirubin is associated with low-density lipoprotein subfractions and particle size in overweight and centrally obese women.

Y-J Kwon1, H-S Lee2, J-W Lee3.   

Abstract

BACKGROUND AND AIMS: Bilirubin has antioxidant and anti-inflammatory properties; serum bilirubin levels have been known to be inversely associated with cardiovascular disease. However, the effects of different bilirubin subtypes on cardiometabolic traits are unknown. In this study, we aimed to determine whether direct bilirubin is more strongly correlated with small, dense low-density lipoprotein (sdLDL) compared to other bilirubin subtypes. We also investigated which LDL subfractions exhibited the highest correlation with direct bilirubin. METHODS AND
RESULTS: A total of 288 overweight and centrally obese women were included in this study. The Pearson correlation and Steiger's Z test were used to compare the correlation coefficients between bilirubin subtypes and lipoproteins. Multiple linear regression analyses were used to evaluate the independent association between direct bilirubin and mean LDL particle size. Only direct bilirubin levels were significantly associated with the sdLDL subfraction and mean LDL particle size. Mean LDL particle size exhibited a significantly stronger correlation with direct bilirubin than sdLDL, percent sdLDL, and the sdLDL:large LDL ratio. Regression analysis showed that direct bilirubin was significantly associated with mean LDL particle size, according to both the stepwise method (β = 11.445, P value = 0.002) and the enter method (β = 11.655, P value = 0.002).
CONCLUSIONS: Direct bilirubin is more strongly correlated with the sdLDL subfraction compared with total and indirect bilirubin, and is independently associated with mean LDL particle size in overweight and centrally obese women.
Copyright © 2018 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Direct bilirubin; LDL subfractions; Mean LDL particle size

Mesh:

Substances:

Year:  2018        PMID: 29983222     DOI: 10.1016/j.numecd.2018.05.013

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  6 in total

Review 1.  Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications.

Authors:  John A McClung; Lior Levy; Victor Garcia; David E Stec; Stephen J Peterson; Nader G Abraham
Journal:  Pharmacol Ther       Date:  2021-09-06       Impact factor: 12.310

2.  Association between total bilirubin and bone mineral density level in adolescents.

Authors:  Jing Wu; Jiali Su; Yangyang Wang; Jianfeng Chen; Yuanyuan Shang; Jing Li
Journal:  BMC Musculoskelet Disord       Date:  2022-07-04       Impact factor: 2.562

3.  Associations between different bilirubin subtypes and diabetic microvascular complications in middle-aged and elderly individuals.

Authors:  Heng Wan; Hui Zhu; Yuying Wang; Kun Zhang; Yi Chen; Sijie Fang; Fangzhen Xia; Ningjian Wang; Wen Zhang; Yingli Lu
Journal:  Ther Adv Endocrinol Metab       Date:  2020-07-11       Impact factor: 3.565

Review 4.  Bilirubin as a metabolic hormone: the physiological relevance of low levels.

Authors:  Justin F Creeden; Darren M Gordon; David E Stec; Terry D Hinds
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-07       Impact factor: 4.310

5.  Systematic Influence of Circulating Bilirubin Levels on Osteoporosis.

Authors:  Jinqiu Zhao; Muzi Zhang; Zhengxue Quan; Liang Deng; Yongguo Li; Bin He
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-26       Impact factor: 5.555

Review 6.  Sample Preparation Methods for Lipidomics Approaches Used in Studies of Obesity.

Authors:  Ivan Liakh; Tomasz Sledzinski; Lukasz Kaska; Paulina Mozolewska; Adriana Mika
Journal:  Molecules       Date:  2020-11-13       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.